on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Interest in Mural Oncology plc
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure in compliance with the Irish Takeover Panel regulations. This disclosure reveals that The Vanguard Group holds a notable 4.48% interest in Mural Oncology plc, equivalent to 772,787 ordinary shares. The latest position was recorded on July 7, 2025.
The filing indicates no other parties are involved in this disclosure, and The Vanguard Group has not entered any other significant agreements or derivative positions concerning Mural Oncology plc. Additionally, The Vanguard Group reports a minor transaction involving the sale of 32 $0.01 ordinary shares at a price of 2.48 USD each.
No derivative transactions or other securities-related agreements are mentioned in the document, nor are there any supplemental forms attached to this disclosure.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news